Skip to main content
GL Pharm Tech Corp. logo

GL Pharm Tech Corp. — Investor Relations & Filings

Ticker · 204840 ISIN · KR7204840003 KO Manufacturing
Open in API
Filings indexed 260 across all filing types
Latest filing 2024-05-03 Major Shareholding Noti…
Country KR South Korea
Listing KO 204840

About GL Pharm Tech Corp.

http://www.glpt.co.kr/

GL Pharm Tech Corp. is a pharmaceutical company specializing in the development of incrementally modified drugs (IMDs). The company focuses on creating improved versions of existing pharmaceutical products by utilizing advanced drug formulation and delivery technologies. Its core mission is to enhance the therapeutic value and safety of marketed drugs, with a specific emphasis on reducing side effects and improving patient convenience. GL Pharm Tech is actively engaged in research and development, managing a pipeline of drug candidates and conducting clinical trials to support the commercialization of its enhanced pharmaceutical products.

Recent filings

Filing Released Lang Actions
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 1% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Capital Markets Act. It details changes in share ownership, specifically reporting a decrease in holdings and the dissolution of a special relationship between the reporting entity (Ideal Private Equity Fund) and other parties. This falls under the category of Major Shareholding Notification (MRQ), as it tracks significant changes in ownership thresholds and relationships.
2024-05-03 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 1% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding of Stocks, etc.), which is a standard regulatory filing in South Korea under the Capital Markets Act. This document is used to report significant changes in share ownership (crossing thresholds or changes in purpose). Based on the provided filing categories, this falls under 'Major Shareholding Notification' (MRQ).
2024-05-02 Korean
기타시장안내(최대주주의의무보유관련) (최대주주의 의무보유 이행 관련)
Major Shareholding Notification Classification · 1% confidence The document is a regulatory announcement from the Korea Exchange regarding GL PharmTech's compliance with mandatory shareholding requirements for its largest shareholder. It is a short, formal notification of regulatory status rather than a financial report, proxy, or earnings release. As it does not fit into specific categories like 'Director's Dealing' or 'Share Issue', it falls under the general regulatory announcement category.
2024-04-30 Korean
[기재정정]최대주주변경
Major Shareholding Notification Classification · 1% confidence The document is a regulatory filing from the Korean stock exchange (KIND/KRX) titled 'Change of Largest Shareholder' (최대주주변경). It details the change in ownership structure, including the number of shares, percentage of ownership, and the identity of the new largest shareholder (더블유사이언스). This type of disclosure is a standard regulatory requirement for public companies to report significant changes in control or major shareholding status. It does not fit into specific categories like 'Director's Dealing' (which is for individual insider trades) or 'Major Shareholding Notification' (which is typically for institutional investors crossing thresholds). Therefore, it is classified as a Regulatory Filing.
2024-04-29 Korean
기타시장안내(최대주주의의무보유관련) (최대주주의 의무보유 대상 확인 관련)
Major Shareholding Notification Classification · 1% confidence The document is a regulatory notice issued by the Korea Exchange (KRX) regarding GL PharmTech. It informs the market about the mandatory share holding requirements for the company's largest shareholder under KOSDAQ listing regulations. Since this is a regulatory announcement regarding market compliance and listing rules rather than a financial report, dividend notice, or management change, it falls under the general regulatory filing category.
2024-04-29 Korean
기타시장안내(최대주주의의무보유관련) (최대주주의 의무보유 이행 관련)
Major Shareholding Notification Classification · 1% confidence The document is a short regulatory announcement from the Korea Exchange regarding GL PharmTech's compliance with mandatory shareholding requirements for its largest shareholder. It is not a financial report, proxy, or dividend notice, but rather a regulatory notification regarding market rules and compliance. Given it does not fit into specific categories like DIRS or SHA, it falls under the general regulatory filing category.
2024-03-27 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.